Canada Respiratory Care Devices Market Overview, 2031

The market for respiratory equipment has undergone a major transformation from its beginnings in acute care within hospitals where ventilators, oxygen delivery systems, and monitoring tools played a vital role to a more mixed model that includes both homecare and outpatient care. Historically, intensive care units ICUs and surgical rooms were the main users of these devices, relying on advanced ventilators, capnographs, and diagnostic spirometers to maintain patient stability during operations and severe respiratory issues. With the increase in chronic illnesses such as COPD, asthma, and sleep apnea, healthcare providers and insurers have acknowledged the advantages of moving specific treatments into community and home environments, which helps shorten hospital stays and enhance quality of life. This shift has been supported by developments in portable oxygen devices, CPAP/BiPAP machines, and intelligent inhalers that enable efficient long-term management of diseases outside hospital settings. In medical practice, respiratory devices are essential for treating asthma and sleep apnea two conditions that pose a significant burden in Canada and managing asthma typically involves the use of nebulizers, peak flow meters, and smart connected inhalers that assist in monitoring symptoms and improving adherence to treatment. Historically, sleep apnea was managed through clinic-based evaluations and CPAP therapy; however, the advent of newer portable and digitally upgraded PAP machines promotes treatment at home with remote tracking for adherence. Advancements like AI-based monitoring and remote respiratory evaluations for example, machine learning algorithms to analyze breathing patterns improve early identification of decreases in lung function, allowing for timely interventions.

According to the research report, " Canada Respiratory Devices Market Overview, 2031," published by Bonafide Research, the Canada Respiratory Devices market was valued at more than USD 871.38 Million in 2025. The Canadian respiratory devices market shows strong growth possibilities with various segments increasing at different speeds. The competitive environment in Canada features a combination of international leaders in medical technology such as Medtronic plc, Philips, GE Healthcare, Fisher & Paykel Healthcare, and Drägerwerk AG, which offer ventilators, systems for oxygen therapy, and PAP devices, along with companies that are working on connected and digital solutions for respiratory care New developments are emphasizing sustainability and the integration of digital health ranging from sustainable materials and energy-saving concentrators to AI-supported remote monitoring systems that integrate patient information into clinician tasks. These developments are influenced by the need for reduced carbon emissions and more tailored care for chronic conditions. Crucially, government reimbursement initiatives and coverage regulations are creating market prospects by reducing financial obstacles for patients. Provincial initiatives, like Ontario’s Assistive Devices Program ADP, offer either full or partial funding for devices such as CPAP machines and home oxygen supplies, provided certain clinical conditions are satisfied, thus broadening access across various population segments. At the national level, the Non-Insured Health Benefits NIHB program covers respiratory devices and supplies for qualifying First Nations and Inuit clients, providing reimbursement options that help boost demand among underserved communities. Moreover, private insurance plans often cover both PAP and oxygen therapies, and tax rules permit claims for medical expenses related to respiratory devices.

Canada Respiratory Devices market by product type is divided into therapeutic devices, monitoring devices, diagnostic devices and consumables and accessories. In Canada, the market for respiratory devices, categorized by product types, reflects the nation's publicly funded health care system, robust hospital infrastructure, and an increasing focus on community-oriented care. Therapeutic devices lead this category, fueled by the common use of ventilators, oxygen concentrators, CPAP/BiPAP apparatus, and nebulizers. Provinces in Canada significantly invested in ventilators and oxygen treatment systems to enhance ICU readiness, resulting in a lasting presence in hospitals. Concurrently, funding initiatives like Ontario’s Assistive Devices Program ADP and equivalent programs in British Columbia and Quebec have expedited the acceptance of oxygen therapy at home and positive airway pressure devices, especially for individuals with sleep apnea and COPD. Monitoring devices represent a swiftly growing segment in Canada, sparked by the healthcare system’s initiative for proactive intervention and remote management of patients. Devices such as pulse oximeters, capnographs, and connected respiratory monitors are now frequently used in hospitals as well as in home care, particularly in rural and isolated areas where specialist access is sparse. The integration with telehealth systems endorsed by provincial health organizations has enabled ongoing monitoring to be an economical method of managing chronic respiratory issues while decreasing hospital readmission rates. Diagnostic devices, which include spirometers, peak flow meters, and polysomnography systems, remain crucial in Canada's respiratory care framework. While specialized sleep labs and pulmonary function evaluations are mostly hospital-based, the use of portable and clinic-friendly diagnostic equipment is rising to combat lengthy waiting periods for specialist exams.

Canada Respiratory Devices market by end user is divided into hospitals, ambulatory care centers, home care settings and other user. The segmentation of end users within the respiratory devices sector in Canada reflects the country's slow shift from a hospital-focused care approach to a more diversified model. Hospitals are still the main users, holding a significant share of the demand for ventilators, sophisticated monitoring tools, and diagnostic machinery. Major urban hospitals and academic health centers act as referral points for intricate respiratory issues, neonatal assistance, and sleep studies, bolstered by provincial health funding and centralized purchasing strategies. Ambulatory Care Centers ACCs and outpatient clinics are becoming increasingly significant as Canada aims to decrease hospital overcrowding and wait times. These facilities are starting to make use of small diagnostic instruments, portable spirometers, and non-invasive breathing devices for treating stable respiratory patients. ACCs are especially important for testing sleep apnea, pulmonary rehabilitation, and managing asthma follow-ups, providing cost-effective options compared to inpatient care while upholding clinical standards. The most rapid expansion is noted in home care environments, showcasing Canada’s strong commitment to facilitating aging in place and self-managing chronic conditions. Home care providers regularly use oxygen concentrators, CPAP machines, nebulizers, and remote monitoring technologies, supported by provincial funds, veterans' programs, and Indigenous health initiatives. Home respiratory services are vital, especially in rural and remote areas where access to hospitals may be limited, allowing for continuous care through remote monitoring. Other end users, including long-term care facilities, rehabilitation organizations, and community health entities, also play a role in generating demand.

"Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031



Aspects covered in this report
• Respiratory Care Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Therapeutic Devices (Inhalers,Ventilators,Positive Airway Pressure (PAP) Devices,Humidifiers,Nebulizers,Others(Oxygen Concentrators, oxygen Hood))
• Monitoring Devices (Pulse Oximeters,Gas Analyzers,Others)
• Diagnostic Devices (Spirometers,Polysomnography Devices,Peak Flow Meters,Others)
• Consumables and Accessories (Disposable Resuscitators,Breathing Circuits,Masks,Tracheostomy Tubes,Others(Nasal Cannulas))
By Disease Indication
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other disease Indications (Respiratory Distress Syndrome, cystic Fibrosis)

By End User
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home care Settings
• Other End User
"